NotizieBenzingaIonis Pharmaceuticals And Partner Roche Said Prespecified Interim Results From Phase 3 IMAgINATION Study Of Sefaxersen For Primary IgA Nephropathy Met Its Primary Endpoint Of Statistically Significant And Clinically Meaningful Improvements In... Ionis Pharmaceuticals And Partner Roche Said Prespecified Interim Results From Phase 3 IMAgINATION Study Of Sefaxersen For Primary IgA Nephropathy Met Its Primary Endpoint Of Statistically Significant And Clinically Meaningful Improvements In... Benzinga 2026.09.23 08:51 (GMT+0) Apri Benzinga Altre notizie UBS avvia copertura su Spyre con rating Buy per potenziale nelle IBD UBS avvia copertura su Protagonist Therapeutics con rating buy Hexcel promossa da Seaport grazie alle prospettive di crescita nella difesa TotalEnergies e KKR aggiungono 700 MW solari alla joint venture negli USA Helikon aumenta la quota in Resolute Mining al 20,1% TotalEnergies e KKR ampliano la joint venture solare negli USA con 700 MW
